1. Home
  2. LDI vs CYBN Comparison

LDI vs CYBN Comparison

Compare LDI & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LDI
  • CYBN
  • Stock Information
  • Founded
  • LDI 2010
  • CYBN 2019
  • Country
  • LDI United States
  • CYBN Canada
  • Employees
  • LDI N/A
  • CYBN N/A
  • Industry
  • LDI Finance: Consumer Services
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • LDI Finance
  • CYBN Health Care
  • Exchange
  • LDI Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • LDI 221.2M
  • CYBN 178.7M
  • IPO Year
  • LDI 2021
  • CYBN N/A
  • Fundamental
  • Price
  • LDI $1.78
  • CYBN $7.95
  • Analyst Decision
  • LDI Sell
  • CYBN Strong Buy
  • Analyst Count
  • LDI 2
  • CYBN 4
  • Target Price
  • LDI $2.05
  • CYBN $85.00
  • AVG Volume (30 Days)
  • LDI 2.2M
  • CYBN 501.0K
  • Earning Date
  • LDI 08-07-2025
  • CYBN 08-07-2025
  • Dividend Yield
  • LDI N/A
  • CYBN N/A
  • EPS Growth
  • LDI N/A
  • CYBN N/A
  • EPS
  • LDI N/A
  • CYBN N/A
  • Revenue
  • LDI $1,090,719,000.00
  • CYBN N/A
  • Revenue This Year
  • LDI $28.34
  • CYBN N/A
  • Revenue Next Year
  • LDI $15.10
  • CYBN N/A
  • P/E Ratio
  • LDI N/A
  • CYBN N/A
  • Revenue Growth
  • LDI 21.07
  • CYBN N/A
  • 52 Week Low
  • LDI $1.01
  • CYBN $4.81
  • 52 Week High
  • LDI $3.23
  • CYBN $13.88
  • Technical
  • Relative Strength Index (RSI)
  • LDI 60.35
  • CYBN 50.75
  • Support Level
  • LDI $1.26
  • CYBN $7.55
  • Resistance Level
  • LDI $2.13
  • CYBN $8.18
  • Average True Range (ATR)
  • LDI 0.15
  • CYBN 0.44
  • MACD
  • LDI 0.03
  • CYBN 0.01
  • Stochastic Oscillator
  • LDI 57.74
  • CYBN 41.83

About LDI loanDepot Inc.

loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

Share on Social Networks: